• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,814.50 1,878.00(%)
  • Jio Platforms
    1,440.80 1,490.00(%)
  • Bharti Airtel
    2,080.70 2,174.70(%)
  • Reliance Industries
    1,307.00 1,611.20(%)
  • BLS Polymers
    285.25 285.25(%)
  • Solar Industries
    20,860.00 22,630.05(%)
  • Multi Comm. Exc.
    3,537.00 3,537.00(%)
  • Aegis Logistics
    1,253.90 1,528.00(%)
  • SBI
    961.35 933.85(%)
  • HDFC Bank
    725.70 1,017.90(%)
  • Oil India
    451.30 395.75(%)
  • Garden Reach Sh.
    2,235.00 3,338.90(%)
  • Divi's Lab.
    10,035.00 10,035.00(%)
  • M & M Fin. Serv.
    267.15 415.00(%)
  • Sagility
    41.98 35.82(%)
  • SFC Enviro.
    424.85 424.85(%)
  • Mankind Pharma
    2,523.70 2,640.30(%)
  • M & M
    2,910.95 3,840.00(%)
  • Kanohar Elect.
    1,165.90 1,210.00(%)
  • Laurus Labs
    2,252.50 913.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Himalaya Nutravedics India Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 96747.0
  • ISIN : INE1OTR01013
127.95 -1 (-0.70%)
  • As on 03 Nov 2026 (EOD)

  • Today’s Low

    115.05

  • Today’s High

    128.45

  • Open

    128.00

  • Perv Close

    128.85

  • 52W Low

    111.00

  • 52W High

    167.20

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    112.68

  • Div & Yield %

    0.00

  • Book Value(₹)

    48.69

  • Debt-Equity Ratio

    -0.70

  • AGM Date

    03-Nov-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    112.68

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    8.81

  • BV (₹)

    48.70

  • Sales( ₹ in Cr.)

    43.07

  • NP (in Cr.)

    7.39

  • NP Var(%)

    231.0

  • Div%

    0.0

  • CPS (₹)

    8.80

  • EPS (₹)

    8.40

  • Traded Value (₹ in Lakhs)

    113.47

  • 52 Week High

    167.20

  • 52 Week Low

    111.00

  • Price BSE

    129.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    113.47

  • P/C Ratio

    14.70

  • P/E Ratio

    15.40

  • Price Vs.BV

    8.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar
INCOME :            
Sales Turnover 43.07 21.00 14.43 2.05 - -
Excise Duty 0.00 0.00 0.00 0.00 - -
Net Sales 43.07 21.00 14.43 2.05 - -
Other Income 0.05 0.00 0.00 0.00 - -
Stock Adjustments -0.15 0.79 0.58 1.00 - -
Total Income 42.97 21.79 15.01 3.05 - -
EXPENDITURE :            
Raw Materials 22.67 13.19 8.79 1.66 - -
Power and Fuel Cost 0.16 0.12 0.13 0.04 - -
Employee Cost 2.46 2.61 2.78 0.43 - -
Other Manufacturing Expenses 3.36 0.79 0.40 0.37 - -
Selling and Administration Expenses 6.14 2.09 1.93 0.25 - -
Miscellaneous Expenses 0.02 0.00 0.03 0.02 - -
Employee Benefit Expenses 2.46 2.61 2.78 0.43 - -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 - -
Total Expenses 34.81 18.80 14.06 2.77 - -
Operating Profit 8.16 2.99 0.94 0.28 - -
Interest 0.35 0.32 0.18 0.02 - -
Gross Profit 7.81 2.67 0.76 0.26 - -
Depreciation 0.33 0.42 0.16 0.06 - -
Profit Before Tax 7.48 2.25 0.60 0.20 - -
Current Tax 0.09 0.02 0.17 0.04 - -
Fringe Benefit tax 0.00 0.00 0.00 0.00 - -
Deferred Tax 0.00 0.00 0.00 0.01 - -
Reported Net Profit 7.39 2.23 0.43 0.15 - -
Extraordinary Items 0.00 0.00 0.00 0.00 - -
Adjusted Net Profit 7.39 2.23 0.43 0.15 - -
Adjustment below Net Profit -0.07 0.00 0.00 0.00 - -
P & L Balance brought forward 2.76 0.53 0.10 0.00 - -
Statutory Appropriations 0.00 0.00 0.00 0.00 - -
Appropriations 0.00 0.00 0.00 0.00 - -
P & L Balance carried down 10.07 2.76 0.53 0.15 - -
Dividend 0.00 0.00 0.00 0.00 - -
Preference Dividend 0.00 0.00 0.00 0.00 - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 - -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 - -
Earnings Per Share-Unit Curr 11.72 5.58 5.13 1.81 - -
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 25.97 16.89 16.33 11.81 - -
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    68.13%

  • Public Share Holding

    31.87%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 6,000,000 68.13 6,000,000 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,000,000 68.13 6,000,000 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 615,600 6.99 615,600 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 615,600 6.99 615,600 2
2] Non Institution
Bodies Corporate 900,504 10.23 900,504 11
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 12,000 0.14 12,000 5
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 47,512 0.54 47,512 11
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 358,386 4.07 358,386 4
Individuals holding nominal share capital up to Rs. 1 lakh 872,318 9.91 872,318 305
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,190,720 24.88 2,190,720 336
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 8,806,320 100.00 8,806,320 344

Company Background

Himalaya Nutravedics India LtdPharmaceuticals - Indian - Formulations

  • Himalaya Nutravedics India Ltd
  • BSE Code : 96747.0
  • ISIN : INE1OTR01013

  • Incorporation Year

    2022

  • Registered Office

    No.101/A Phase 3 Indu.Dev.Park
    Cherlapally Hindustan Cables L, Hyderabad,
    Telangana-500051

  • Telephone

    +91 90634 98493

  • FAX

  • Chairman

    Rohit Asawa

  • Managing Director

    Rohit Asawa

  • Company Secretary

    Pooja Biyani

  • Auditor

    J Singh & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    KFin Technologies Ltd
    301 The Centrium,
    3rd Flr 57 LBS,Nav Pada Kurla(W)
    Mumbai - Mumbai-400 070

Himalaya Nutravedics India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Himalaya Nutravedics 127.95 43.12 43.07 0.00 51.73
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77